TRITON is a phase III study of combinations of molecules, namely CHF 5993 or CHF 1535, administered by inhalation for the control of chronic obstructive pulmonary disease.
You may receive one of the two combinations of medications. The treatment is administered by inhalation.
To participate, you must have received a diagnosis of COPD.
Clic here to access the official record from the National Library of Medicine for this study